Cite
MLA Citation
S. Hingorani et al.. “2321 High response rate and progression free survival with PEGylated recombinant human hyaluronidase added to Nab-Paclitaxel/ Gemcitabine in stage IV previously untreated pancreatic cancer patients with high-HA tumors: Interim results of a randomized Phase 2 study.” European journal of cancer, vol. 51, n.d., pp. S439–S440. http://access.bl.uk/ark:/81055/vdc_100030628218.0x00003b